LCM
AMPH icon

Landscape Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Landscape Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,603
Closed -$214K – 505
2016
Q4 		$214K Buy
+11,603
New +$226K 0.03% 469

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Landscape Capital Management's AMPH Position: Q1 2017 in Review

Landscape Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2017, closing a stake of 11,603 shares — an estimated $214K sold.

Landscape Capital Management first reported a position in AMPH in Q4 2016 and held it in 1 quarter. The position peaked at $214K in Q4 2016. 116 funds tracked by Wall St. Rank hold AMPH as of Q1 2017.

  • Landscape Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Landscape Capital Management sold 11,603 Amphastar Pharmaceuticals shares in Q1 2017, an estimated $214K.
  • Landscape Capital Management first reported a position in Amphastar Pharmaceuticals in Q4 2016 and held it in 1 quarter.
  • Landscape Capital Management's Amphastar Pharmaceuticals position peaked at $214K in Q4 2016.
  • 116 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2017.

Based on Landscape Capital Management's 13F filing for Q1 2017, filed 12 May 2017.